Egyptian International Pharmaceutical Industries Company SAE · PHAR.CA

Egyptian International Pharmaceutical Industries Company SAE is an Egypt-based pharmaceuticals business in the healthcare sector, listed on the Egyptian Exchange under ticker PHAR.CA. Egyptian International Pharmaceuticals Industries Co SAE (EIPICO) is an Egypt-based public shareholding company that operates in the pharmaceuticals industry. Egyptian International Pharmaceutical Industries Company SAE is a manufacturer and exporter of pharmaceuticals, and holds license agreements with a group of international pharmaceutical companies to produce their products locally and replace the imported ones. Egyptian International Pharmaceutical Industries Company SAE produces dosage forms, such as spansule capsules (long-acting), as well as non-traditional dosage forms, such as the soft gelatin capsules, lyophilized products, gels, sprayers and effervescent tablets. EIPICO exports its products to Arab countries, as well as African, Asian and East European Countries. Its investment profile is best assessed through product quality, regulatory compliance, distribution, pricing, and demand from Egypt’s healthcare market. Key analysis points include business model clarity, durability of revenue sources, cost control, cash conversion, leverage, shareholder structure, and the consistency of public disclosures over time.